Whole-Genome Sequence Analysis, Probiotic Potential, and Safety Assessment of the Marine Bacterium Paraliobacillus zengyii CGMCC1.16464
Marine Drugs · 2025
DOI: 10.3390/md23050202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Qianjin Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Academician Innovation Platform Research Special Project, CSRD VA, specific research fund of the Innovation Platform for Academicians of Hainan Province.
Abstract (Originalsprache)
Paraliobacillus zengyii CGMCC1.16464 (P. zengyii) is a novel antiviral probiotic candidate strain. To ensure its safety as a potential probiotic, a safety evaluation was conducted in this study. The safety and functional potential of P. zengyii were systematically assessed through genomic bioinformatics analysis, in vitro experiments, and acute oral toxicity tests in mice. Genomic analysis revealed that P. zengyii is rich in genes related to carbohydrate and amino acid metabolisms and carries genes encoding antimicrobial and antiviral agents (such as ectoine, type III polyketide synthase, and lasso peptides). It also expresses gastrointestinal tolerance-related proteins (ClpC, GroEL, and ClpP). Its resistance to polymyxins is an inherent trait with no risk of plasmid-mediated transfer. In vitro experiments confirmed that P. zengyii is somewhat tolerant to bile salts and acidic environments and does not exhibit hemolytic or gelatinase activity. Importantly, an acute oral toxicity test in mice revealed that after intervention with high, medium, or low doses, no significant abnormalities in the body weight, organ index, or tissue morphology of the mice were observed. In conclusion, P. zengyii exhibited good safety and probiotic potential in terms of genomic safety, metabolic function, and in vitro and in vivo toxicities, providing a theoretical basis for the development of novel functional probiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, China.
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
- Center of Reverse Microbial Etiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Zhijie Cao
Förderung
- Hainan Provincial Academician Innovation Platform Research Special Project
- CSRD VA
- specific research fund of the Innovation Platform for Academicians of Hainan Province
- National Key Laboratory of Intelligent Tracking, Forecasting for Infectious Diseases (NITFID) of China CDC
Zitieren
APA
Fan, Q., Jiao, M., Huangfu, H., Chen, L., Li, B., Cao, Z., Luo, X., & Xu, J. (2025). Whole-Genome Sequence Analysis, Probiotic Potential, and Safety Assessment of the Marine Bacterium Paraliobacillus zengyii CGMCC1.16464. Marine Drugs. https://doi.org/10.3390/md23050202
Vancouver
Fan Q, Jiao M, Huangfu H, Chen L, Li B, Cao Z, et al. Whole-Genome Sequence Analysis, Probiotic Potential, and Safety Assessment of the Marine Bacterium Paraliobacillus zengyii CGMCC1.16464. Marine Drugs. 2025. doi:10.3390/md23050202
BibTeX
@article{Fan2025,
author = {Fan, Qianjin and Jiao, Mengqi and Huangfu, Haoyue and Chen, Lan and Li, Beijie and Cao, Zhijie and Luo, Xuelian and Xu, Jianguo},
title = {Whole-Genome Sequence Analysis, Probiotic Potential, and Safety Assessment of the Marine Bacterium Paraliobacillus zengyii CGMCC1.16464},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23050202}
}
EUVIMED